Amino Acid Changes in a Unique
Sequence of Bacteriophage T7 DNA
Polymerase Alter the Processivity
of Nucleotide Polymerization
The Harvard community has made this
article openly available.
Please share
how
this access benefits you. Your story matters
Citation
Yang, Xiao-Ming, and Charles C. Richardson. 1997. “Amino
Acid Changes in a Unique Sequence of Bacteriophage T7 DNA
Polymerase Alter the Processivity of Nucleotide Polymerization.”
Journal of Biological Chemistry 272 (10): 6599–6606. https://
doi.org/10.1074/jbc.272.10.6599.
Citable link
http://nrs.harvard.edu/urn-3:HUL.InstRepos:41483338
Terms of Use
This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://
Amino Acid Changes in a Unique Sequence of Bacteriophage
T7 DNA Polymerase Alter the Processivity of Nucleotide
Polymerization*
(Received for publication, October 29, 1996)
Xiao-Ming Yang and Charles C. Richardson‡
From the Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115
T7 gene 5 DNA polymerase forms a complex with Esch-erichia colithioredoxin (its processivity factor), and a 76-amino acid sequence (residues 258 –334), unique to gene 5 protein, has been implicated in this interaction. We have examined the effect of amino acid substitu-tion(s) in this region on T7 phage growth and on the interaction of the polymerase with thioredoxin. Among the mutations in gene5, we found that a substitution of either Glu or Ala for Lys-302 yielded a protein that could not complement T7 phage lacking gene5(T7D5) to grow onE. colihaving reduced thioredoxin levels. One triple mutant (K300E,K302E,K304E) could not support the growth of T7D5 even in wild type cells. This altered polymerase is stimulated 4-fold less by thioredoxin than is the wild type enzyme and the polymerase-thioredoxin complex has reduced processivity. The exonuclease ac-tivity of the altered polymerase is not stimulated to the same extent as that of the wild type enzyme by thiore-doxin. The observed dissociation constant of the gene 5 protein K(300,302,304)E-thioredoxin complex is 7-fold higher than that of the wild type complex. The altered polymerase also has a lower binding affinity for double-stranded DNA.
Protein-protein interactions are essential for the coordina-tion of the multiple reaccoordina-tions that occur at a replicacoordina-tion fork. Although the replication machinery of bacteriophage T7 is sim-ple in comparison to that of its host, Escherichia coli, specific interactions among the relatively few proteins are important (1–3). In fact, the economy of proteins involved in T7 DNA replication has made it an attractive model for dissecting their interactions. An essential component of the T7 replisome is the T7 DNA polymerase, the 80-kDa product of gene 5 of the phage. Gene 5 protein physically interacts with the hexameric gene 4 protein of the phage, a protein that provides both helicase and primase activity at the replication fork to coordinate both lead-ing and lagglead-ing strand synthesis (2, 4 – 6). Both the gene 5 and gene 4 proteins in turn interact with the T7 gene 2.5 protein, a single-stranded DNA (ssDNA)1-binding protein that stimulates
both polymerase and primase activities (4, 7, 8). Thus, all three
of these phage-encoded proteins physically interact with one another.
In addition to the interactions of the T7 DNA polymerase with the other two phage-encoded proteins, the gene 5 protein also physically interacts with one host protein, E. coli thiore-doxin (9 –12). Thiorethiore-doxin forms a stable one-to-one complex with T7 gene 5 protein with an apparent dissociation constant of 5 nM(13). The consequence of the interaction is to convert
gene 5 protein from a polymerase with low processivity of polymerization of nucleotides to one of high processivity (9 –12). The increased processivity arises as a result of the 80-fold greater affinity of the DNA polymerase-thioredoxin complex for a primer-template (13, 14). T7 gene 5 protein also has a 39to 59 exonuclease activity that is active on both ssDNA and double-stranded DNA (dsDNA) (9, 15). Thioredoxin stimulates activity on dsDNA but the activity on ssDNA is not affected. The enhanced activity on dsDNA is most likely due to a higher affinity of the polymerase-thioredoxin complex to the 39 -ter-mini, resulting in increased processivity of hydrolysis (14).
Studies on both E. coli thioredoxin and T7 gene 5 protein have provided information on the domains in each protein that are important for the interactions of the two proteins. Thiore-doxin, a 12-kDa protein that contains an active center consist-ing of two cysteine residues (Cys-32 and Cys-35) that can form a disulfide bridge, provides the reducing power for a number of reactions in E. coli (16 –18). However, the active-center cys-teines are not essential for the interaction of thioredoxin and gene 5 protein, since genetically altered thioredoxins in which either one or both Cys have been replaced with Ser, form a functional complex with gene 5 protein and support T7 phage growth (13). Other studies have implicated a group of residues (Gly-33, Pro-34, Ile-75, Pro-76, Gly-92, and Ala-93) that form a hydrophobic surface as being involved in interactions with a number of other proteins (17, 19). The three-dimensional struc-tures of both oxidized (20) and reduced thioredoxin (21) are known; these residues are located in three loops formed be-tweenb-sheet 2 (b2)-a-helix 2 (a2),a3-b4, andb5-a4, and all face the same side of the thioredoxin molecule. A comparison of the structures of oxidized and reduced thioredoxin reveals that the transition of Cys-32 and Cys-35 between reduced and oxi-dized forms introduces a significant change in the position of Pro-34, resulting in a local conformational change around Cys-35. This conformational change could explain why only reduced thioredoxin binds to gene 5 protein (20). Genetic (22) and bio-chemical analyses (13, 23) of thioredoxin mutants that are defective in supporting T7 phage growth have shown that mu-tations at Cys-32, Cys-34, Gly-74, and Gly-92 affect the binding of thioredoxin to gene 5 protein, suggesting that the same
* This investigation was supported in part by Grant AI-06045 from the National Institutes of Health and Grant DE-GF88ER60688 from the Department of Energy. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ Consultant to Amersham Life Science Inc., which has a license from Harvard University to commercialize DNA polymerases for use in DNA sequencing. To whom correspondence should be addressed. Tel.: 617-432-1864; Fax: 617-432-3362; E-mail: [email protected].
1The abbreviations used are: ss, single-stranded; ds,
double-strand-ed; PCR, polymerase chain reaction; PAGE, polyacrylamide gel
electro-phoresis; DTT, 1,4-dithiothreitol; BSA, bovine serum albumin; bp, base pair(s).
© 1997 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www-jbc.stanford.edu/jbc/
6599
by guest on October 5, 2019
http://www.jbc.org/
hydrophobic surface of thioredoxin is also involved in its inter-action with T7 gene 5 protein. Several other residues in thiore-doxin have also been postulated to be involved in the interac-tion with gene 5 protein: Pro-34, Gly-74, and Gly-92 (13, 22); recently, it has been proposed that the active-site cysteines, Gly-74, and Gly-92 define part of the thioredoxin surface that contacts gene 5 protein (23, 24).
Although the three-dimensional structure of T7 DNA polym-erase is not known, it shares a high degree of homology to the large fragment of E. coli DNA polymerase I (25), whose crystal structure is known (26, 27). Furthermore, a number of studies indicate that the active sites of the enzyme are similar and that the two proteins share some structural similarities. For exam-ple the polymerase activity site of T7 DNA polymerase, like that of E. coli DNA polymerase I, resides within the carboxyl-terminal half of the molecule, while the 39to 59 proofreading domain is located within the amino-terminal half of the mole-cule (24, 28). Furthermore, relatively large segments of the polypeptide chain that constitutes the polymerase active site of
E. coli DNA polymerase I can be exchanged with the
homolo-gous region of T7 DNA polymerase with retention of polymer-ase activity (29).
Two lines of evidence suggest that at least a portion of the thioredoxin binding domain of gene 5 protein resides within the polymerase domain. T7 DNA polymerase purified in the ab-sence of thioredoxin is subject to proteolytic attack at three clustered sites that lie within the COOH-terminal region of the protein, and this proteolysis is inhibited by thioredoxin (9). Mapping of these sites showed the proteolytic cleavage to re-side at positions Ile-289, Lys-299, and Ala-323 of the T7 gene 5 protein (24). These results implicated the sequence Ile-289 to Ala-323 as a region that physically interacts with thioredoxin. This sequence, which does have a homologous counterpart in E.
coli DNA polymerase I (30, 31), has an unusually high content
of hydrophilic residues. In the structure of the large fragment of E. coli DNA polymerase I, this 76-amino acid sequence is located in a region referred to as the “thumb” that partially covers the crevice through which the DNA passes, a region that has been proposed to be involved in the interaction of the polymerase with duplex DNA (27). Further evidence suggest-ing that this unique amino acid sequence interacts with thiore-doxin comes from studies on suppressor mutations that allow T7 phage to use a genetically altered thioredoxin (22). One suppressor mutation (Glu-3193Lys) resides within this re-gion and restores the ability of T7 DNA polymerase to interact with this particular mutant thioredoxin (23).
In this report we have introduced specific amino acid changes into this unique hydrophilic region of T7 gene 5 pro-tein. We show that alteration of amino acid within this se-quence results in the failure to support the growth of T7 phage due to decreased binding of the polymerase to thioredoxin and reduced processivity of the polymerase-thioredoxin complex.
EXPERIMENTAL PROCEDURES Materials
E. coli strains, Bacteriophage, and Plasmids—E. coli strains
A307OmpT (HrfC, DtrxA307, ompt2), HMS249 (F2, opt Al, dapD4), C600, C600trxA2 (trxA gene deletion), HMS157 (F2, recC22, sbcA5,
endA2, gal2, thi2, sup2), HMS157trxA2, and HB101 are from the laboratory collection. Wild type bacteriophage T7 is from the laboratory collection, and mutant phages T7D5 (gene 5 deletion), T7trx5 (E. coli
trxA gene inserted into T7 phage genome between genes 1 and 1.1) were
from S. Tabor (Harvard Medical School). Plasmid pGP5–3 containing wild type T7 gene 5 under control of T7 RNA polymerase promoter was obtained from S. Tabor (Harvard Medical School) (9). M13mGP1–2 is a 9950-base pair derivative of phage M13 containing an insert of phage T7 DNA, which expresses T7 RNA polymerase upon induction by iso-propyl-1-thio-b-D-galactopyranoside (9). Growth and manipulation of
bacteriophage T7 and E. coli were performed as described (28, 32, 33).
Nucleotides, Oligonucleotides, and DNA—M13mp18 DNA and the
23-mer universal cycle sequencing primer were obtained from Amer-sham Life Sciences, Inc. Calf thymus DNA was from Sigma. Oligonu-cleotides of the xy52 series used for mutagenesis (each harbors one of the mutated amino acid codons), JH10 (59 -CCTTTAATCCTGCGGCG-39) complementary to T7 gene 5 and Liu12 (59 -TACGACTCACTAT-CAGGGAG-39) complementary to T7 RNA polymerase promoter of plas-mid pGP5–3, are from the laboratory collection. Nucleoside 59 -triphosphates (dNTPs) were from Pharmacia Biotech Inc. [a-32P]dTTP
(800 Ci/mmol, 1 Ci537 Gbq), [g-32P]ATP (3000 Ci/mmol), [a-32P]dATP
(3000 Ci/mmol), and [3H]dTTP (15 Ci/mmol) were products of DuPont
NEN or Amersham Life Science, Inc.
Proteins—Purified bacteriophage T7 gene 5 protein and gene 2.5
protein were obtained from S. Tabor (Harvard Medical School). T7 gene 4 proteins were provided by S. Notarnicola and B. B. Beauchamp (Harvard Medical School). E. coli thioredoxin and endonuclease AvaI are products of Amersham Life Science, Inc. Bovine serum albumin was from Miles Laboratories. Ampli-Taq®DNA polymerase was from
Per-kin Elmer. Polyclonal antiserum specific to gene 5 protein and to E. coli thioredoxin was from Hazelton Research Products, Inc.
Other Materials—dsDNA-cellulose was obtained from B. B. Beauchamp (Harvard Medical School). DEAE-Sephadex A-50, Sepha-rose CL-2B cellulose (P-11), and DE-81 filter discs were obtained from Whatman. Microspin Columns were products of Pharmacia Biotech Inc. Bio-Spin Chromatography columns, Mini-Protein ready gels, and pro-tein silver stain kits were purchased from Bio-Rad. Propro-tein electro-phoresis standards were from Amersham Life Science, Inc. Premixed polyacrylamide solutions were from Boehringer Mannheim or National Diagnostics. 1,4-Dithiothreitol (DTT) is the product of ICN Biochemi-cals Inc.
Methods
DNA Manipulation—If not indicated specifically, DNA manipulation
were performed according to the protocols described (34). DNA se-quence analysis was performed using the method of dideoxynucleotide chain-termination (35) with Sequenase 2.0 (Amersham Life Science, Inc.).
Site-directed Mutagenesis—In vitro mutagenesis of bacteriophage T7
gene 5 was carried out by using a modified “overlap extension” method as described elsewhere (36). Two partially overlapping oligonucleotide primers (xy52 series), each bearing appropriate codons corresponding to the desired amino acid residue substitution in the overlapping region, were used in the polymerase chain reaction (PCR) (37) to generate each mutant T7 gene 5. Each mutagenesis involved three separate PCR reactions. For example, two oligonucleotide primers, xy52–5 (59 -TCTC-GCTGTGCCTTGTTCTCAGGCTTTTTAAAGATACC-39) and xy52–5c (59-GGTATCTTTAAAAAGCCTGAGAACAAGGCACAGCG-39), were used to replace the Lys-302 (AAG) to a Glu (GAG) in gene 5 protein. The underlined codon corresponds to the amino acid residue alteration. In the first PCR, the oligonucleotide primer (xy52–5) and one upstream primer (Liu12) were used to generate a 980-base pair (bp) fragment. Another oligonucleotide primer (xy52–5c) and a downstream primer (JH10) were used in the second PCR to generate a fragment of 900 bp. The 980- and 900-bp fragments from the first two PCR were mixed and used as a template in the third PCR in the presence of the upstream (Liu12) and downstream (JH10) primers. The product from the third PCR (1800 bp) was digested with restriction enzymes MunI and HpaI, and the resulting fragment was ligated into the MunI and HpaI site of pGP5–3 giving rise to pGP5–3K302E. All the mutants were prepared in a similar way as described above. All clones were confirmed by DNA sequencing.
Preparation of DNA Substrates—Circular M13 DNA to which a
25-nucleotide oligo25-nucleotide primer was annealed was used in the polym-erase and processivity assays. In the latter assay, the oligonucleotide was radioactively labeled at its 59-terminus using polynucleotide kinase and [g-32P]ATP (34). After incubation at 37 °C for 30 min followed by 15
min at 70 °C, the labeled oligonucleotide was annealed to M13mp18 DNA in the presence of MgCl2(10 mM) and NaCl (100 mM). After
purification using an S300 Spin-Column, the DNA was extracted with an equal volume of phenol/chloroform. The DNA was precipitated with ethanol (34) and dissolved in TE buffer.
DNA for use in the exonuclease assay was uniformly labeled [3H]dsDNA and ssDNA. dsDNA (1,800 base pairs) was amplified by
PCR using primers JH10 and Liu12 in the presence of [3H]dTTP and
three other nucleoside triphosphates. The PCR products were isolated by S400 Spin-Columns and digested with endonuclease AvaI, generat-ing a fragment of 1600 base pairs with protrudgenerat-ing cohesive 59termini.
Mutations Affecting Processivity of T7 DNA Polymerase
6600
by guest on October 5, 2019
http://www.jbc.org/
After separation on an agarose gel, the desired DNA was purified by GeneClean (Bio 101, Inc.) and stored in TE buffer (specific activity 15–20 cpm/pmol). ssDNA was prepared by incubating the [3H]dsDNA
with 1M NaOH for 5 min at room temperature. The solution was neutralized by the addition of 1MHCl and 1 mMEDTA.
Generation of Phage T7D5trxA—DNA isolated from phage T7trx5
and T7D5 were digested with endonuclease BglII, which cleaves the T7 DNA once at position 11,515, giving rise to two DNA fragments. The shorter fragment contains T7 DNA from position 1 to 11,515, and the longer fragment contains T7 DNA from position 11,516 to the 39-end of the molecule. The shorter fragment from T7trx5 and the longer frag-ment from T7D5 were isolated and ligated, and the ligated DNA was transfected into E. coli HMS157 harboring plasmid pGP5–3 (HMS157/ pGP5–3). The transformed cells were plated on E. coli C600 harboring plasmid pGP5–3 (C600/pGP5–3). Individual phage plaques were picked, and the phages were screened for their ability to grow on HMS157trxA2/pGP5–3.
Determination of Thioredoxin Production in Cells Infected with Phage T7D5trxA—In order to measure the production of thioredoxin in E. coli infected with phage T7D5trxA, E. coli C600 and C600trxA2, each harboring the plasmid pGP5–3 (C600/pGP5–3, C600trxA2/pGP5–3), were grown in LB medium (33) at 37 °C. At an A590of 1.0, the cells were
infected with wild type T7 and with T7D5trxA phage, at a multiplicity of infection of 5 phage. Aliquots of the culture were transferred before and after infection, and the cells were lysed in buffer containing 1.25% sodium dodecyl sulfate, 60 mMTris-HCl, pH 6.8, 12.5% glycerol, 30 mM
2-mercaptoethanol, and 0.014% bromphenol blue. After separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, proteins were electroblotted onto polyvinylidene difluoride membranes and the proteins detected with polyclonal antibodies specific to gene 5 protein and E. coli thioredoxin. The results were analyzed by a densitometer.
Phage Complementation Assays—Plating efficiencies of T7D5 and T7D5trxA phage were measured as follows. E. coli strains C600 or C600trxA2harboring plasmids containing wild type or one of the mu-tated T7 gene 5 were grown to 23108cells/ml. Various phage (either
T7D5 or T7D5trxA) diluted in LB medium (0.1 ml) were mixed with 0.1 ml of E. coli cell culture and 3 ml of top agar. The mixtures were plated on LB or LB/ampicillin plates and incubated at 37 °C.
Overproduction and Purification of Mutant Gene 5 Protein—The
plasmid pGP5–3KE containing the mutated gene 5 was used to produce the altered gene 5 protein designated gp5K(300,302,304)E, which has three amino acid substitutions: K300E, K302E, and K304E. E. coli A307OmpT harboring the plasmid pGP5–3KE were grown at 37 °C, and at an A590 of 1, gene 5 expression was induced by infection with
M13mGP1–2 and the addition of isopropyl-1-thio-b-D
-galactopyrano-side to a concentration of 0.3 mM(9). Three hours later, the cells were harvested by centrifugation at 10,0003g for 10 min at 4 °C. Cell pellets
were washed twice with ice-cold 2-fold volumes of High EDTA Buffer (50 mMTris-HCl, pH 7.5, 10% sucrose, 25 mMEDTA), and twice with
Low EDTA Buffer (50 mMTris-HCl, pH 7.5, 10% sucrose, 5 mMEDTA). Purification of altered gene 5 protein was performed as described (9).
Reconstitution of Gene 5 Protein-Thioredoxin Complex—The gene 5
protein-thioredoxin complex found in T7-infected E. coli cells can be reconstituted from purified T7 gene 5 protein and E. coli thioredoxin (9). The gene 5 protein-thioredoxin complex was reconstituted by incuba-tion of gene 5 protein and thioredoxin in ice for 5 min at a 1:1000 molar ratio (0.1mg of gene 5 protein:15mg of thioredoxin). The mixture was then diluted into 40 mMTris-HCl, pH 7.5, 5 mMDTT, 0.5 mg/ml BSA (19) before use.
DNA Polymerase Assay—DNA polymerase activity was measured in
an assay based on previously described procedures (23). The primer-template used was either heat-denatured calf thymus DNA (0.1 mg/ml) or single-stranded M13 DNA annealed to a 23-mer oligonucleotide (17 nM). The reaction mixture (25–50 ml) contained, in addition to the primer-template, 40 mMTris-HCl, pH 7.5, 10 mMMgCl2, 50 mMNaCl,
1 mM DTT, 0.1 mg/ml BSA, 0.3 mM each dATP, dGTP, dCTP, and [3H]dTTP (final specific activity is 3– 4 cpm/pmol). Reactions were
ini-tiated by the addition of enzyme. After 15 min at 37 °C, reactions were terminated by the addition of EDTA to 50 mM. The3H-labeled DNA
product was adsorbed onto DEAE-81 filters, and the radioactivity was measured as described (23).
39to 59Exonuclease Assay—39to 59exonuclease activity of DNA polymerase was determined as described previously (23) using uni-formly labeled dsDNA or ssDNA. The reaction (50ml) contained 40 mM
Tris-HCl, pH 7.5, 10 mMMgCl2, 50 mMNaCl, 5 mMDTT, and 1200 pmol
of [3H]DNA (in nucleotide equivalent). The reactions were initiated by
the addition of enzyme (2 nM). After 15 min at 37 °C, the reactions were
terminated by the addition of EDTA to 50 mM. DNA was precipitated by
the addition of 15ml of an ice-cold solution of bovine serum albumin (10 mg/ml) and 15ml of an ice-cold solution of trichloroacetic acid (100%). After 15 min on ice, the mixture was centrifuged for 30 min at 13,0003
g at 4 °C and the acid-soluble radioactivity in the supernatant was
measured by liquid scintillation counting.
Processivity Assay—Processivity of nucleotide polymerization in the
gene 5 protein polymerase reaction was analyzed by a method previ-ously described (23) using a circular M13 ssDNA annealed to a 59-32
P-labeled oligonucleotide primer (BCMP-57, 59- TTTTCCCAGTCAC-GACGTTGTAAAACGACGGCCAGTGCCA-39). After labeling at the 59 -end with T4 polynucleotide kinase, the oligonucleotide was annealed to M13mp18 DNA, and the primer-template was purified using a Gene-Clean kit (Bio 101, Inc.). The reaction mixture (25ml) containing 20 nM
primer-template and the same components described for the polymer-ase assay was preincubated at 37 °C for 1 min, and then the reaction was initiated by the addition of enzyme (a mixture of 2 nM gene 5 protein and 2 mME. coli thioredoxin). After incubation at 37 °C for
various times, aliquots were removed and added to a solution contain-ing EDTA (final concentration 50 mM), and DNA synthesis products were separated by agarose gel electrophoresis. After electrophoresis, the gels were dried, and DNA products were analyzed by autoradiography.
DNA-cellulose Chromatography—To further investigate the effect of
amino acid substitutions in gene 5 protein, we analyzed the affinity of the altered protein for DNA. DNA binding was measured by a modifi-cation of a procedure described previously (13). Purified wild type gene
5 protein (15mg) and gp5K(300,302,304)E (15mg), were diluted in 0.4 ml of the Binding Buffer (40 mMTris-HCl, pH 7.5, 10 mMNaCl, 2 mM
DTT, and 5% glycerol), and applied to a 0.5-ml column of dsDNA-cellulose by gravity flow. The columns were washed with five column volumes of the Binding Buffer, and the proteins were then eluted with a step gradient with 4 ml of Binding Buffer, each containing either 0.1, 0.2, 0.3, 0.4, 0.5, 0.75, or 1MNaCl. A portion of each fraction was transferred for assay of polymerase activity, the remaining portion was supplemented with 25mg of BSA, and the proteins were precipitated by the addition of two volumes of 24% trichloroacetic acid. Fractions were analyzed by Western blots with polyclonal antibodies to gene 5 protein and E. coli thioredoxin.
RESULTS
As described in the Introduction, earlier studies have impli-cated a 76-amino acid sequence (residues 258 –334) in T7 gene 5 protein as the thioredoxin binding domain (23, 24).2 This
sequence, unique to T7 DNA polymerase, is inserted into the thumb region of the polymerase domain based on the homology of T7 DNA polymerase to E. coli DNA polymerase I (25). To further examine the role of this domain in T7 DNA polymerase, we have made amino acid substitutions in the 76-amino acid sequence and examined the effect of these changes on T7 DNA polymerase function both in vivo and in vitro.
Construction of Gene 5 Protein Mutants—Within the
76-amino acid sequence composing the postulated thioredoxin binding domain, there are 9 lysine residues. We have made single amino acid substitutions for 5 of these lysine residues, three in the cluster of 5 lysine residues located at one terminus of the segment and one each in the center and at the other terminus. In addition we have also constructed gene 5 mutants that contain either double or triple substitutions in the cluster of five lysine residues. Basically, for the construction of each mutant, directed mutagenesis was carried out using PCR and the appropriate primers, two of which contained the desired mutation (see “Experimental Procedures”). Each construction was verified by DNA sequence analysis. The resulting gene 5 mutants are presented in Table I.
Complementation System for Gene 5 Protein-thioredoxin In-teraction—The basis for the complementation assay used to
examine the gene 5 mutants is the in vivo requirement for a functional T7 gene 5 protein and E. coli thioredoxin for T7 DNA replication and phage growth (1, 13). Since a functional inter-action between the gene 5 protein and thioredoxin is dependent
2X.-M. Yang and C. C. Richardson, unpublished results.
by guest on October 5, 2019
http://www.jbc.org/
on the intracellular concentration of thioredoxin (22), we have designed the complementation system such that the thiore-doxin concentration can be reduced below that normally pres-ent in E. coli. In this manner it is possible to idpres-entify altered gene 5 proteins that support T7 growth at high levels of thi-oredoxin but not at lower levels, a consequence of a decreased affinity of the two proteins.
As illustrated in Fig. 1A, we have inserted the structural gene for E. coli thioredoxin, trxA, into the phage T7 genome to create the recombinant phage T7D5trxA. The trxA gene is located just downstream from T7 gene 1; hence, upon infection of E. coli, it is transcribed by the host RNA polymerase (38). Once the product of gene 1, T7 RNA polymerase, is produced, it transcribes the majority of the phage genes, one of which, gene
2, encodes an inhibitor of E. coli RNA polymerase (38).
Conse-quently, the amount of thioredoxin produced in a E. coli trxA2 cells infected with T7D5trxA phage should be limited. T7D5trxA phage also contains a deletion of gene 5, the struc-tural gene for T7 DNA polymerase. Hence, phage growth is dependent on expression of a plasmid-encoded gene 5, pGP5–3. Plasmid pGP5–3 harbors T7 gene 5 under the control of a T7 RNA polymerase promoter (9) so that gene 5 is expressed upon infection by phage T7.
Upon infection of E. coli C600 by wild type T7 phage at 37 °C, gene 5 protein appears approximately 10 min after infection and reaches the maximum level at 30 min (Fig. 1B). The host thioredoxin, in contrast, is maintained at a approximately con-stant level. T7D5trxA-infected E. coli C600trxA2/pGP5–3 begin to produce thioredoxin at 10 min after infection, but the level obtained is approximately 5-fold lower than that normally present in E. coli, as judged by densitometry of the gels shown in Fig. 1B. Gene 5 protein is present at levels similar to that found in wild type phage-infected cells at 30 min after infection.
Analysis of Gene 5 Mutants—The effect of each of the
muta-tions in gene 5 on phage T7 growth was examined by meas-uring the ability of the altered gene 5 proteins expressed from the cloned genes to complement T7 lacking gene 5 (Table I). The complementation assays were carried out using infection of
E. coli C600 and C600trxA2by T7D5trxA phage, respectively. Expression of the trxA gene located on the phage leads to
intracellular levels of thioredoxin lower than that obtained when the E. coli chromosomal gene is expressed.
As shown in Table I, phage T7 lacking gene 5 grow normally when gene 5 protein is produced from a plasmid encoding the wild type gene, but not in its absence. Furthermore, T7D5trxA capable of supplying its own thioredoxin can grow on E. coli lacking the trxA gene provided that gene 5 protein is also expressed from the cloned gene, E. coli C600trxA2/pGP5–3.
When plated on E. coli C600, all of the plasmids containing a single or double mutation in gene 5 can complement and sup-port the growth of T7D5trxA (Table I). However, the triple mutant, T7 gp5K(300,302,304)E, cannot. Under more stringent conditions in which the intracellular concentration of thiore-doxin is reduced by supplying thiorethiore-doxin from the phage, gene 5 proteins containing the single amino acid changes K302A and K302E cannot complement T7D5trxA, nor can the double tant, K300E,K302E. Under this condition another single mu-tation, K300E, also resulted in a 10-fold lower plating efficiency compared with that of wild type gene 5.
The polymerase and 39to 59exonuclease activities of all the altered gene 5 proteins were examined by overexpressing each mutant gene in E. coli BL21(DE3). Both activities of all the genetically altered gene 5 proteins were indistinguishable from that of wild type gene 5 protein when assayed in cell extracts containing thioredoxin (Table I). This result strongly implies that this unique region of gene 5 protein is not involved with either the polymerase or exonuclease active site, a conclusion that is in agreement with our previous results that proteolytic fragments missing this region retain polymerase and exonucle-ase activity (24).
Purification of Mutant Gene 5 Protein, gp5K(300,302, 304)E—Based on the results of the complementation analysis,
implying that the triple mutant protein, gp5K(300,302,304)E, is more defective than any of the single mutant proteins, we purified gp5K(300,302,304)E from extract of cells over-produc-ing this protein and characterized it biochemically. The five-step purification procedure includes (NH4)SO4 precipitation
and DEAE- and phosphocellulose chromatography (9). SDS-PAGE analysis of the isolated protein revealed that the pre-dominant polypeptide migrates at a position corresponding to a
TABLE I
Ability of gene 5 mutants to support T7 growth
Plating efficiencies of T7D5 and T7D5trx A phage on E. coli C600 and C600trxA2were measured as described under “Experimental Procedures.”
Plasmid Amino acid substitution T7 growth
a In vitro assay
T7D5 (C600) T7D5trxA (C600trxA2) Polb Exob
3109pfu/ml %
No plasmid ,0.001 ,0.001 ,1 ,1 pT7 No gene 5 ,0.001 ,0.001 ,1 ,1 pGP5–3 Wild type 100 100 100 100 pT7-gp5 Wild type 110 110 100 100 pGP5–3K268E K268E 90 90 95 96 pGP5–3K285A K285A 90 100 94 96 pGP5–3K285G K285G 80 90 93 93 pGP5–3K285E K285E 90 80 94 96 pGP5–3K300E K300E 50 5 93 90 pGP5–3K302E K302E 40 ,0.001 94 96 pGP5–3K302A K302A 50 ,0.001 95 96 pGP5–3K304E K304E 70 70 93 95 pGP5–3K K300E,K302E 3 ,0.001 85 73 pGP5–3KA K300A,K302A 5 ,0.001 91 75 pGP5–3KE K300E,K302E,K304E ,0.001 ,0.001 90 70
aE. coli C600 or C600trxA2cells harboring the indicated plasmids were infected with phage T7D5 or phage T7D5trxA, respectively. The number
of plaques on each plate were counted, and an average from three experiments are presented as phage formation units (pfu)/ml of phage solution.
bDNA polymerase and exonuclease activities in extracts prepared from E. coli BL21(DE3) cells transformed with each of the gene 5-containing
plasmids were determined in the presence of E. coli thioredoxin (3mM) using heat-denatured calf thymus DNA and [3
H]dsDNA as described under “Experimental Procedures.” Based on the observation that all of the level of expression of all of the cloned genes was approximately the same, the activities are presented as a percentage of the wild type gene 5 protein activity. The specific activity of polymerase (;2000 pmol of dNMP incorporated/min/mg of protein) and 39to 59exonuclease (;2500 pmol of dNMP hydrolyzed/min/mg of protein) of the wild-type enzyme were presented as 100%.
Mutations Affecting Processivity of T7 DNA Polymerase
6602
by guest on October 5, 2019
http://www.jbc.org/
molecular mass of approximately 80 kDa and reacts to antibody specific to gene 5 protein (data not shown). The protein is 85% pure, as estimated by densitometry analysis of the Coomassie Brilliant Blue-stained gel.
DNA Polymerase and Exonuclease Activities of the gp5K(300,302,304)E Protein—Both the polymerase and 39to 59 exonuclease activities of the purified gp5K(300,302,304)E were determined and compared with those of the wild type enzyme, both in the presence and absence of thioredoxin (Table II). In the absence of thioredoxin, the polymerase specific activity of the mutant enzyme is essentially identical to that of wild type gene 5 protein. However, in the presence of thioredoxin, the wild type gene 5 protein is stimulated approximately 600-fold, whereas the mutant protein is stimulated only 150-fold. Like the wild type enzyme, the mutant protein also catalyzes the hydrolysis of ssDNA, a reaction that is not stimulated by thi-oredoxin (Table II). Although the exonuclease activity of both enzymes on dsDNA is stimulated by thioredoxin, the stimula-tion is 3-fold less with the mutant enzyme.
Processivity of Mutant Gene 5 Protein—Thioredoxin
stimu-lates the activity of wild type gene 5 protein by increasing the processivity of polymerization of nucleotides (9). Therefore, the most likely explanation for the lack of stimulation of the po-lymerase activity of gp5K(300,302,304)E by thioredoxin is due to a failure to achieve processivity. We have compared the processivity of wild type gene 5 protein and the mutant enzyme in the presence of thioredoxin using a dilution experiment in which DNA synthesis was carried out using a32P-end-labeled
primer-M13 template with a 4-fold excess of primer-template over polymerase (Fig. 2). Thus the DNA synthesis observed from the extension of a given primer is the result of a single binding event by the polymerase (9). The processivity of wild type gene 5 protein in the presence of thioredoxin is in the order of hundreds of nucleotides resulting in the accumulation of full-length 7000-nucleotide M13 molecule within the short pe-riod of the incubation. In contrast, the products of synthesis by the mutant enzyme in the presence of thioredoxin are consid-erably shorter, and no full-length molecules are observed (Fig.
2). Furthermore, there is a decrease in the amount of unrepli-cated primer-template indicative of the rapid cycling of the mutant enzyme. Although not shown, in the absence of thiore-doxin the products synthesized by both enzymes are less than 50 nucleotides in length at 1 min of incubation, as judged by polyacrylamide gel electrophoresis analysis.
T7 gene 2.5 protein, as well as E. coli ssDNA-binding protein, stimulate the processivity of nucleotide polymerization cata-lyzed by the gene 5 protein-thioredoxin complex, presumably by removing secondary structures within ssDNA (8, 9). How-ever, T7 gene 2.5 protein also physically interacts with T7 DNA polymerase, an interaction that may affect processivity through a different mechanism (8). As shown in Fig. 3, al-though the gene 5 protein-thioredoxin complex alone is highly processive, the presence of gene 2.5 protein dramatically in-creases processivity. However, the increase in processivity by gene 2.5 protein is without effect on gene 5 protein alone. Again, the T7 gp5K(300,302,304)E-thioredoxin complex has lower processivity, but interestingly the addition of gene 2.5 protein increases processivity resulting in the formation of full-length product molecule (Fig. 3).
Binding Affinity of gp5K(300,302,304)E and Thiore-doxin—T7 gene 5 protein and E. coli thioredoxin physically
interact with a stoichiometry of 1:1 (10 –12). The consequence
FIG. 1. Diagram of phage T7D5trxA and expression of thetrxAgene. A, schematic representation of phage T7D5trxA. T7 genes are
represented by open boxes, the locations of the E. coli trxA gene is indicated by a filled box, and the BglII site is shown. Gene 5 normally located between gene 4 and 6 has been deleted. The construction and characterization of the recombinant phage is described under “Experimental Procedures.” B, immunoanalysis of extracts of infected cell for thioredoxin and gene 5 proteins. E. coli C600 and E. coli C600trxA2/pGP5–3 were infected with wild type T7 and T7D5trxA, respectively, in LB medium at 37 °C. At the indicated times, the cells were collected by centrifugation and aliquots were subjected to SDS-PAGE. After electrophoresis, the proteins were transferred onto polyvinylidene difluoride membranes, and gene 5 protein and thioredoxin were detected by polyclonal antibodies specific to T7 gene 5 protein and E. coli thioredoxin. M, mixture of the purified gene 5 protein and E. coli thioredoxin. Arrows at left indicate the positions of gene 5 protein (filled arrow) and E. coli thioredoxin (open
arrow). The locations of molecular weight markers are shown at the right.
TABLE II
Comparison of specific activity of gp5K(300,302,304)E
DNA polymerase and exonuclease activities of the purified wild type and mutant gene 5 proteins were determined as described under “Ex-perimental Procedures.”
Polymerase activity Exonuclease activity
Primed M13 DNA ssDNA dsDNA
pmol dNMP/min/mg protein
pmol dNMP/min/mg protein
gp5wt 300 60,400 8,300 gp5wt/Trx 170,000 130,000 583,330 gp5K(300,302,304)E 320 6,250 6,280 gp5K(300,302,304)E/Trx 50,000 8,000 150,000
by guest on October 5, 2019
http://www.jbc.org/
of this interaction is to increase the affinity of the polymerase to a primer-template, which in turn leads to an increase in the processivity of polymerization of nucleotides (14). To quantita-tively assay the interaction between gp5K(300,302,304)E and thioredoxin, the observed equilibrium dissociation constant (Kobs) between the gene 5 protein and thioredoxin was
deter-mined as described previously (13). The results of binding assays between the mutant gene 5 protein and wild type gene 5 protein with E. coli thioredoxin are presented in Fig. 4. From inspection of Fig. 4, it is evident that the lysine to glutamate mutations in gene 5 protein decrease the binding affinity to thioredoxin as compared to wild type gene 5 protein. Based on the assumption that the DNA polymerase activity is propor-tional to the concentration the gene 5 protein-thioredoxin com-plex and that the free thioredoxin concentration is equal to that of the added total thioredoxin, we calculated the Kobsfor the
binding of gp5K(300,302,304)E with thioredoxin at 37 °C to be 56 nMand that of the wild type gene 5 protein with thioredoxin to be 8 nM. This latter value is in agreement with that of 5 nM
determined earlier at 30 °C (13). We conclude that the muta-tions in gp5K(300,302,304)E lead to a decreased affinity for
thioredoxin, resulting in a reduced processivity of polymerization.
DNA Binding—Amino acid changes in the mutant gene 5
protein represent changes of three positively charged residues to three negatively charged residues. We compared the affinity of the mutant protein for DNA to that of the wild type protein. Interestingly, the gp5K(300,302,304)E binds less tightly to a DNA-cellulose column than does the wild type gene 5 protein (Fig. 5). As in the case of the wild type gene 5 protein-thiore-doxin complex, the mutant gene 5 protein-thioreprotein-thiore-doxin complex has a higher affinity for DNA-cellulose. The possible signifi-cance of this result is addressed under “Discussion.”
DISCUSSION
High processivity, the ability to polymerize thousands of nucleotides during each binding cycle, is an important property for DNA polymerases involved in the replication of a chromo-some. The diversity with which the DNA polymerases of differ-ent organisms have acquired this essdiffer-ential function is illus-trated by eukaryotes, E. coli, and bacteriophagesf29, T4, T5, and T7. The DNA polymerases of both phagef29 (14) and T5 (40, 41) are highly processive by themselves, although the molecular mechanism by which they achieve this property is not at present known. By contrast, the T4 DNA polymerase and the replicative DNA polymerases of E. coli and eukaryotes associate with separate proteins that function as clamps to tether the polymerase to the primer-template (42). These ho-mologous proteins (T4 gene 45 protein, E. colibsubunit, and eukaryotic proliferating cell nuclear antigen) form multimers that encircle the duplex region of the primer-template (43– 45). Bacteriophage T7 DNA polymerase, the subject of this report, we believe to lie between these two extremes in that the po-lymerase and its processivity factor, E. coli thioredoxin, form the clamp that encircles the dsDNA. Thus, as discussed in more detail below, we propose that the DNA polymerase itself serves as one side of the clamp, and thioredoxin the other.
In the Introduction we discussed the high affinity of thiore-doxin for T7 gene 5 protein, the increased affinity of the com-plex for a primer-template, and the resulting increase in pro-cessivity of polymerization of nucleotides. Here we show that amino acid changes in a 76-amino acid region of gene 5 protein (residues 258 –333) decrease its affinity for thioredoxin and the processivity of the polymerization reaction. The rationale for selecting this particular sequence for site-directed mutagenesis
FIG. 2. Processivity of nucleotide polymerization catalyzed by
wild type gene 5 protein and mutant protein. DNA synthesis
reactions were carried out using a 5932P-labeled primer (23-mer)
an-nealed to M13mp18 DNA as described under “Experimental Proce-dures.” The reactions contained 0.4 pmol of DNA and were initiated by the addition of reconstituted gene 5 protein-thioredoxin complex (0.1 pmol). The reactions were incubated at 37 °C, and at the indicated times aliquots were removed from each reaction. The products were separated by agarose-gel electrophoresis. The gel was dried and ana-lyzed by autoradiography. Markers on the left (0 and 7000) refer to the number of nucleotide incorporated as judged by32P-labeled
HindIII-digestedlDNA.
FIG. 3. Stimulation of processivity of nucleotide
polymeriza-tion catalyzed by gene 5 protein by gene 2.5 protein. Processivity
assays were carried out as described in the legend to Fig. 2, except that the indicated amounts of T7 gene 2.5 protein were added together with the gene 5 protein and reactions were incubated for 1 min at 37 °C.
FIG. 4. Scatchard plot of the binding of gp5wt and gp5K(300,302,304)E to thioredoxin. The purified T7 gene 5 proteins
(0.05 pmol), gp5wt (E) or gp5K(300,302,304)E (f), were mixed with increasing concentration of thioredoxin at 0 °C for 10 min. The amount of DNA synthesis was measured as described under “Experimental Procedures,” and the data were used to generate a Scatchard plot. The observed equilibrium dissociation constant (Kobs) for each gene 5
pro-tein-thioredoxin complex was the negative slope of the line that best fitted the data.
Mutations Affecting Processivity of T7 DNA Polymerase
6604
by guest on October 5, 2019
http://www.jbc.org/
is based on several considerations. First, T7 gene 5 protein is subject to a specific proteolytic cleavage within this region that enables the separation of the carboxyl-terminal polymerase domain from the amino-terminal 39to 59exonuclease domain (23). Thioredoxin partially protects the gene 5 protein from cleavages within this region. Second, proteolytic cleavage at residue Lys-299 gives rise to a carboxyl-terminal domain con-taining polymerase activity that is not stimulated by the addi-tion of thioredoxin (23). Third, one mutaaddi-tion in gene 5 protein, Glu-3193Lys, which lies within this 76-amino acid sequence, suppresses a mutation in thioredoxin that cannot support the growth of T7 phage (21). The suppressor gene 5 protein has enhanced binding to the mutant thioredoxin, and the amino acid changes suggest a contact point between the two proteins (22). Fourth, E. coli DNA polymerase I, an enzyme highly homologous to T7 gene 5 protein (23), does not have this 76-amino acid sequence and does not bind thioredoxin (23, 47). Finally, the T7 unique sequence, based on homology of T7 DNA polymerase to the large fragment of E. coli DNA polymerase I whose structure is known (25), is inserted into the thumb region of the polymerization domain. The thumb region has been proposed to play an important role in binding E. coli DNA polymerase I to duplex DNA, providing it with a processivity of approximately 20 nucleotides/binding cycle (26).
We initially replaced five lysine residues within the 76-a-mino acid region with glutamate, on the assumption that the replacement of a negatively charged group with a positively charged group would most likely have an affect on the binding
of the protein to thioredoxin. However, replacement of individ-ual lysine residues with glutamate did not alter the ability of the gene 5 protein to complement in wild type E. coli cells infected with T7 phage lacking gene 5. Only when the cellular concentration of thioredoxin was reduced did a gene 5 protein having a single amino acid change, K302A, fail to complement, although the K300E complemented relatively poorly. The re-quirement of high concentrations of thioredoxin to achieve complementation suggests strongly that the affinity of the al-tered gene 5 proteins and thioredoxin is reduced, a result observed previously (13). A more severe defect was observed when all three lysines were simultaneously replaced by gluta-mates. In this instance wild type levels of thioredoxin could not support growth of T7.
In order to determine the basis of the defect in the T7 gp5K(300,302,304)E, we purified the protein and characterized it biochemically. Although both the polymerase and 39 to 59 exonuclease activities of the enzyme were equivalent to that of the wild type gene 5 protein, it had a 7-fold lower affinity for E.
coli thioredoxin and, as a consequence, the processivity of
nu-cleotide polymerization catalyzed by the polymerase-thiore-doxin complex was not nearly as high as that of the wild type complex. The severe affect of only a 7-fold reduction in binding of the mutant polymerase to thioredoxin on DNA replication and phage growth is not unanticipated, since the single amino acid change E319K in gene 5 protein increases its affinity for a mutant thioredoxin only 6-fold but restores phage growth on cells harboring this thioredoxin. We did not purify the T7 gp5K302E, gp5K302A, or gp5K(300,302)A, but we presume that their affinity for thioredoxin is reduced by an even lesser extent, since the defect is observed in vivo only when the intracellular concentration of thioredoxin is reduced.
The effect of thioredoxin on the dsDNA exonuclease activity of the mutant gene 5 protein also supports a decrease in pro-cessivity of the enzyme. The stimulation of the dsDNA exonu-clease activity of wild type gene 5 protein by thioredoxin re-flects the increased binding of the enzyme to the 39-termini of a duplex DNA molecule in the presence of thioredoxin (14). Our finding that thioredoxin does not stimulate the dsDNA exonu-clease of the mutant protein to the same extent as that ob-served with the wild type gene 5 protein suggests that the mutant gene 5 protein-thioredoxin complex binds less tightly to the DNA. We did not determine the apparent dissociation con-stant, Kobs, from these data, but based on the similar values of Kobsfor polymerase and dsDNA exonuclease reported from this
laboratory (13), we assume it should be similar to that derived from the effect of thioredoxin on the polymerase activity of gene 5 protein.
By what mechanism do these mutations reduce the binding of the protein to thioredoxin? In the case of the previously described E319K mutation in gene 5 protein that was isolated as a suppressor mutation that allowed the phage to grow on a strain containing an altered thioredoxin (G74D), we believe that the residue at position 319 provides a contact point for residue 74 in thioredoxin. This conclusion is based on both in
vivo and in vitro results, as well as the nature of the amino acid
changes (20, 21). We suspect, however, that the affect of the changes in the three lysine residues described here on binding to thioredoxin are due to more complex interactions between the two protein. Although there is good evidence that the struc-ture of T7 gene 5 protein resembles closely that of the large fragment of E. coli DNA polymerase I the 76-amino acid se-quence in which these mutations reside is unique to T7 gene 5 protein. Not only is the structure of this segment unknown, but its effect on adjacent domains must await structure determi-nation of T7 DNA polymerase. One approach to extending the
FIG. 5. DNA binding activity of gene 5 proteins in the presence
and absence of thioredoxin. Gene 5 proteins, wild type or
gp5K(300,302,304)E, were reconstituted with thioredoxin as described under “Experimental Procedures.” The reconstituted gene 5 protein-thioredoxin complex (1Trx) or the gene 5 protein alone (2Trx) were
loaded onto a dsDNA-cellulose column (0.5 ml), and the column was then washed with successive washes of 4 ml of Binding Buffer contain-ing the indicated concentration of NaCl. Fractions were assayed for polymerase activity using heat-denatured calf thymus DNA as de-scribed under “Experimental Procedures.” B, before loading; F, flow-through; W, washing buffer.
by guest on October 5, 2019
http://www.jbc.org/
mechanism by which amino acid changes in this 76-amino acid segment decrease binding to thioredoxin would be to identify suppressor mutations in the trxA gene. The resulting amino acid changes in thioredoxin and the biochemical properties of the altered thioredoxin should provide additional information on the interaction of the two proteins.
It also appears that the triple amino acid changes in gp5K(300,302,304)E have a secondary effect of decreasing the affinity of the gene 5 protein for DNA. The mutant gene 5 protein-thioredoxin complex has a higher affinity for DNA-cellulose than does the mutant gene 5 protein alone, as is the case for wild type gene 5 protein. However, the affinity of the mutant complex is still less than that observed with the wild type complex. Whether this decreased binding is a consequence of the substitution of three negative charges for three positive ones or simply a conformational change in the protein is not known. However, the decreased binding may explain the in-ability to compensate completely for the reduced affinity of gp5K(300,302,304)E for thioredoxin in stimulating polymerase activity by increased concentrations of thioredoxin even though the Kobs of gp5K(300,302,304)E to thioredoxin is only 7-fold
higher than that of wild type gp5. The decreased binding of gp5K(300,302,304)E to DNA complicates the role of thioredoxin in stimulating polymerase activity of this particular protein, since thioredoxin binding to this domain may in part mask the effect of the negative charges on DNA binding and increase activity by this mechanism. We believe that the decreased affinity of altered gene 5 protein-thioredoxin complex to DNA is not the major effect of the observed higher Kobs of
gp5K(300,302,304)E to thioredoxin, although the measurement of Kobsis dependent on the polymerase activity, which itself could be affected by the interaction between the protein and DNA. Additional studies have provided more evidence that this region binds to thioredoxin (see below).
The present studies were carried out to obtain additional support for the unique 76-amino acid segment in T7 DNA polymerase being the thioredoxin domain. Our results showing that, as predicted, alteration of amino acid residues within this sequence affects thioredoxin binding add to that body of evi-dence. Does the identification of the thioredoxin binding do-main assist in understanding the mechanism by which thiore-doxin confers high processivity on T7 DNA polymerase? Based on the homology between T7 gene 5 protein and the large fragment of E. coli DNA polymerase I, the 76-residue domain is located between helices H and H1in the large fragment of E. coli DNA polymerase I. The H helix is one of the two large a
helices, H and I, that are connected by two shorterahelices, H1 and H2. These helices constitute the thumb region of the large fragment of E. coli DNA polymerase I and in the crystal of this enzyme with DNA the amino terminus of the H1helix fits into
the minor groove of the duplex DNA molecule (24), leading to the hypothesis that the thumb region may stabilize the enzyme to the DNA and thus increase the processivity of polymeriza-tion. The location of the 76-amino acid sequence thus enables thioredoxin to bind in a position that places it over the duplex portion of the primer-template essentially forming a clamp that encircles the DNA. In view of the strong evidence that the unique 76-residue segment found in T7 DNA polymerase is the thioredoxin domain and the high degree of homology between this enzyme and the large fragment of E. coli DNA polymerase
I, we have recently inserted this segment into the homologous site in the large fragment of E. coli DNA polymerase I. The chimeric DNA polymerase now binds thioredoxin and displays an increase in processivity (47). These results, taken together with the evidence presented above, leave little doubt that the 76-amino acid sequence is a major constituent of the thiore-doxin binding domain.
REFERENCES
1. Richardson, C. C. (1983) Cell 33, 315–317
2. Debyser, Z., Tabor, S., and Richardson, C. C. (1994) Cell 77, 157–166 3. Kim, Y. T., and Richardson, C. C. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,
10173–10177
4. Nakai, H., and Richardson, C. C. (1988) J. Biol. Chem. 263, 9831–9839 5. Romano, L. J., and Richardson, C. C. (1979) J. Biol. Chem. 254, 10483–10489 6. Notarnicola, S. M., Park, K., Griffith, J. D., and Richardson, C. C. (1995)
J. Biol. Chem. 270, 20215–20224
7. Scheringer, E., Liftin, G., and Jost, E. (1973) Mol. Gen. Genet. 123, 247–262 8. Kim, Y. T., Tabor, S., Churchich, J. E., and Richardson, C. C. (1992) J. Biol.
Chem. 267, 15032–15040
9. Tabor, S., Huber, H. E., and Richardson, C. C. (1987) J. Biol. Chem. 262, 16212–16223
10. Modrich, P., and Richardson, C. C. (1975) J. Biol. Chem. 250, 5508 –5514 11. Modrich, P., and Richardson, C. C. (1975) J. Biol. Chem. 250, 5515–5522 12. Mark, D. F., and Richardson, C. C. (1976) Proc. Natl. Acad. Sci. U. S. A. 73,
780 –781
13. Huber, H. E., Russel, M., Model, P., and Richardson, C. C. (1986) J. Biol.
Chem. 261, 15006 –15012
14. Huber, H. E., Tabor, S., and Richardson, C. C. (1987) J. Biol. Chem. 262, 16224 –16232
15. Hori, K., Mark, D. F., and Richardson, C. C. (1979) J. Biol. Chem. 254, 11598 –11604
16. Holmgren, A. (1981) Curr. Top. Cell. Regul. 19, 47–76 17. Holmgren, A. (1985) Annu. Rev. Biochem. 54, 237–271
18. Holmgren, A., and Bjornstedt, M. (1995) Methods Enzymol. 252, 199 –208 19. Eklund, H., Cambillau, C., Sjo¨berg, B.-M., Holmgren, A., Jo¨rnvall, H., Ho¨o¨g,
J.-O., and Bra¨nde´n, C. I. (1984) EMBO J. 3, 1443–1449 20. LeMaster, D. M., and Katti, S. K. (1990) J. Mol. Biol. 212, 167–184 21. Dyson, H. J., Gippert, G. P., Case, D. A., Holmgren, A., and Wright, P. E.
(1990) Biochemistry 29, 4129 – 4136
22. Himawan, J. S., and Richardson, C. C. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 9774 –9778
23. Himawan, J. S., and Richardson, C. C. (1996) J. Biol. Chem. 271, 19999 –20008 24. Yang, X., and Richardson, C. C. (1996) J. Biol. Chem. 271, 24207–24212 25. Ollis, D. S., Kline, C., and Steitz, T. A. (1985) Nature 313, 818 – 819 26. Ollis, D. L., Brick, P., Hamlin, R., Xuong, N. G., and Steitz, T. A. (1985) Nature
313, 726 –766
27. Beese, L. S., Derbyshire, V., and Steitz, T. A. (1993) Science 260, 352–355 28. Tabor, S., and Richardson, C. C. (1989) J. Biol. Chem. 264, 6447– 6458 29. Tabor, S., and Richardson, C. C. (1995) Proc. Natl. Acad. Sci. U. S. A. 92,
6339 – 6343
30. Bernad, A., Blasco, L., and Salas, M. (1991) Gene (Amst.) 100, 27–38 31. Scarlato, V., and Gargano, S. (1992) Gene (Amst.) 118, 109 –113 32. Studier, F. W. (1969) Virology 39, 562–574
33. Studier, F. W. (1975) J. Mol. Biol. 94, 283–295
34. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A
Laboratory Manual, 2nd Ed., Cold Spring Harbor Laboratory, Cold Spring
Harbor, NY
35. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A.
74, 5463–5467
36. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989)
Gene (Amst.) 77, 51–59
37. Saiki, R., Scharf, S. J., Faloona, F., Mullis, K. B., Horn, H. A., and Arnheim, N. (1985) Science 242 1350 –1354
38. Dunn, J. J., and Studier, F. W. (1983) J. Mol. Biol. 166, 477–535 39. Deleted in proof
40. Blanco, L., Bernad, A., Lazaro, J. M., Martin, G., Garmendia, C., and Salas, M. (1989) J. Biol. Chem. 264, 8935– 8940
41. Fujimura, R. K., and Roop, B. C. (1976) J. Biol. Chem. 251, 2168 –2175 42. Das, S. K., and Fujimura, R. K. (1979) J. Biol. Chem. 254, 1227–1232 43. Kuriyan, J., and O’Donnell, M. (1993) J. Mol. Biol. 234, 915–25
44. Kong, X.-P., Onrust, R., O’Donnell, M., and Kuriyan, J. (1992) Cell 69, 425– 437
45. Krishna, T. S., Kong, X. P., Gary, S., Burgers, P. M., and Kuriyan, J. (1994)
Cell 79, 1233–1243
46. Gogol, E. P., Young, M. C., Kubasek, W. L., Jarvis, T. C., and van Hippel, P. H. (1992) J. Mol. Biol. 224, 395– 412
47. Bedford, E., Tabor, S., and Richardson, C. C. (1997) Proc. Natl. Acad. Sci.
U. S. A. 94, in press
Mutations Affecting Processivity of T7 DNA Polymerase
6606
by guest on October 5, 2019
http://www.jbc.org/
Xiao-Ming Yang and Charles C. Richardson
Alter the Processivity of Nucleotide Polymerization
Amino Acid Changes in a Unique Sequence of Bacteriophage T7 DNA Polymerase
doi: 10.1074/jbc.272.10.6599
1997, 272:6599-6606.
J. Biol. Chem.
http://www.jbc.org/content/272/10/6599
Access the most updated version of this article at
Alerts:
When a correction for this article is posted
•
When this article is cited
•
to choose from all of JBC's e-mail alerts
Click here
http://www.jbc.org/content/272/10/6599.full.html#ref-list-1
This article cites 44 references, 22 of which can be accessed free at
by guest on October 5, 2019
http://www.jbc.org/
